Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

QSAR analysis of substituent effects on tambjamine anion transporters

Nicola J. Knight a, Elsa Hernando b, Cally J. E. Haynes§ a, Nathalie Busschaert a, Harriet J. Clarke a, Koji Takimoto c, María García-Valverde b, Jeremy G. Frey *a, Roberto Quesada *b and Philip A. Gale *a
aChemistry, University of Southampton, Southampton, SO17 1BJ, UK. E-mail: philip.gale@soton.ac.uk; J.G.Frey@soton.ac.uk; Tel: +44 (0)23 8059 3332
bDepartamento de Química, Facultad de Ciencias, Universidad de Burgos, 09001 Burgos, Spain. E-mail: rquesada@ubu.es
cOrganic and Polymeric Materials, Tokyo Institute of Technology, 2-12-1 O-okayama, Tokyo 152-8552, Japan

Received 16th October 2015 , Accepted 17th November 2015

First published on 8th December 2015


Abstract

The transmembrane anion transport activity of 43 synthetic molecules based on the structure of marine alkaloid tambjamine were assessed in model phospholipid (POPC) liposomes. The anionophoric activity of these molecules showed a parabolic dependence with lipophilicity, with an optimum range for transport efficiency. Using a quantitative structure–transport activity (QSAR) approach it was possible to rationalize these results and to quantify the contribution of lipophilicity to the transport activity of these derivatives. While the optimal value of log[thin space (1/6-em)]P and the curvature of the parabolic dependence is a property of the membrane (and so similar for the different series of substituents) we found that for relatively simple substituents in certain locations on the tambjamine core, hydrophobic interactions clearly dominate, but for others, more specific interactions are present that change the position of the membrane hydrophobicity parabolic envelope.


Introduction

The control of the transmembrane transport of ions is an essential function of living organisms. This control is essentially exerted by transmembrane proteins, although there are small lipophilic molecules (ionophores) capable of facilitating the transmembrane transport of ions.1,2 The vast majority of identified natural ionophores are cation selective. Nevertheless, anion transport is no less important and the characterization of the facilitated transmembrane anion transport by both natural and synthetic systems is receiving increasing attention.3–8 These molecules could have potential in the treatment of conditions derived from the defective regulation of chloride and bicarbonate transport such as cystic fibrosis or Bartter's syndrome.9,10 Moreover naturally occurring cationophores find applications as antimicrobials and biomembrane research tools, thus, anion selective ionophores could find similar applications.

Among the identified naturally occurring anionophores, the structurally related prodiginines and tambjamine alkaloids are the most studied examples.11 These compounds show interesting pharmacological properties including antitumor activity.12,13 The synthetic prodiginine analogue obatoclax has been shown to display promising anticancer activity in the clinic.14 We have demonstrated that the ionophoric activity of these compounds is related to their cytotoxicity.15 Active ionophores are able to disrupt intracellular pH gradients and to trigger apoptosis in cancer cells.16–19

An increasing number of synthetic molecules capable of facilitating anion transport by forming lipophilic supramolecular complexes or membrane spanning channels have been reported in the literature.20–23 Despite this progress, the knowledge of the requirements for designing effective anion transporters remains poor, and identification of active derivatives is mostly based on trial/error methods. Qualitative structure–transport activity studies underscored lipophilicity as one of the most important factors influencing the ionophoric transport activity of these compounds.24 Moreover, Gale, Davis and co-workers have also introduced the concept of lipophilic balance in the design of these compounds.25 Quantitative structure–activity relationship (QSAR) approaches are widely employed in medicinal chemistry. QSAR constitutes a powerful tool to assist rational molecular design and to predict different physicochemical properties.26 Recently, we have reported a quantitative structure–transport activity (QSAR) study of the anion binding and transport of a series of 1-hexyl-3-phenylthioureas bearing various substituents at the para- positions of the aromatic ring.27 This study allowed us to determine a statistically relevant model correlating anion transport activity with parameters such as lipophilicity, the Hammett coefficient of the varied substituent and SPAN, a descriptor for molecular size. Prompted by this success we decided to perform a more ambitious study introducing several structural changes on the studied molecules. We aimed to investigate a series of effective anion transporters having a range of lipophilicity values as well as transport activities. In this regard, the tambjamine alkaloids represent ideal candidates because of their synthetic accessibility and tolerance to different substituents while remaining as potent transmembrane anion transporters. In this work we present a QSAR study of the transmembrane anion transport activity of 43 tambjamine inspired transporters, aimed to shed light on the structural design requirements to successful anion carriers and the quantification of the relationships between lipophilicity and transmembrane anion transport activity of small molecules.

Results and discussion

A series of tambjamine derivatives 1–43 were selected for this study (Fig. 1). Tambjamines are marine alkaloids containing a 4-methoxy-2,2′-bipyrrole core. Some of the studied compounds are natural products such as tambjamine B (20), tambjamine C (31), tambjamine K (32) or BE-18591 (30), whereas others are synthetic tambjamine analogues. With this selection we aimed to create a library of compounds including systematic variations on the enamine substituent and also to explore the possibility of replacing the –OMe group characteristic of naturally occurring derivatives by a benzyloxy group. The synthesis of these compounds is straightforward from the appropriate bipyrrolealdehyde.28 Compounds 5, 9, 20–32, 34, 35, 37–40 and 42 have been previously reported and all of them were characterized by standard methods.29
image file: c5sc03932k-f1.tif
Fig. 1 Compounds included in this study.

Anion transport assays

In order to measure the transmembrane transport activity of compounds 1–43, the chloride efflux from 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) chloride containing vesicles was monitored over time using a chloride selective electrode, according to reported methods.30 Briefly, 200 nm POPC liposomes containing chloride (489 mM NaCl, 5 mM phosphate buffer pH 7.2) were prepared. The vesicles were then suspended in an isotonic nitrate solution (489 mM NaNO3, 5 mM phosphate buffer pH 7.2) and the studied compound added as a DMSO solution (typically 10 μL or less to avoid any influence in the outcome of the experiment). Chloride release is then monitored over 300 s using a chloride selective electrode. A final reading, considered to be 100% chloride release, was obtained after addition of detergent to lyse the vesicles. The transport assays were repeated at different carrier concentrations. The data was subjected to Hill analyses in order to obtain a quantitative measure of the transporter efficiency.31 Thus the effective concentrations required to induce 50% of chloride efflux in the time scale of the experiments (300 s) were calculated (EC50, Table 1). Hill analyses also provided the Hill parameter n values. The Hill parameters were all consistent with a mobile carrier mechanism.32 All the studied compounds were found to be highly active anion carriers, with EC50 values of 0.003–0.346 mol% carrier/lipid. The initial rate of chloride release (kini) was also calculated for carrier loadings of 0.05 mol% compound to POPC. An overview of all these data is provided in Table 1.
Table 1 Overview of transmembrane anion transport data: EC50, n, initial rate of chloride release (kini), log[thin space (1/6-em)]P and retention timesa
Compound EC50b Hill parameter n k ini log[thin space (1/6-em)]Pd Retention time (min)
a n.d. not determined. b molar percentage with respect to POPC, mol%. c Values calculated by fitting the plot of relative chloride release (y) versus time (x) for 0.05 mol% compound to lipid to an asymptotic function y = ab × cx. The initial rate of chloride release (kini in % s−1) is given by −b[thin space (1/6-em)]ln(c). d Log[thin space (1/6-em)]P values calculated using ALOGPs 2.1 software. e Determined via correlation between kini and EC50 (see ESI).
1 0.00719 1.19 0.952 3.08 10.4
2 0.00613 1.23 1.41 3.74 11
3 0.00699 1.25 1.24 4.17 11.6
4 0.00779 1.32 1.17 4.63 12.2
5 0.0104 1.29 1.02 4.72 11.9
6 0.00951 1.25 1.13 5.02 12.7
7 0.288 0.965 0.0231 7.11 14.5
8 0.0688 1.42 0.229 2.58 8.8
9 0.0197 1.29 0.638 2.86 9.8
10 0.0134 1.28 0.786 3.37 10.5
11 0.0231 1.31 0.470 3.76 11
12 0.0260 1.29 0.494 3.2 10.4
13 0.0208 1.18 0.474 2.92 9.6
14 0.0155 1.27 0.661 3.49 10.3
15 0.0236 1.37 0.444 3.62 10.5
16 0.0221 1.29 0.510 3.76 10.8
17 0.0167 1.48 0.830 2.68 9
18 0.0494 1.59 0.314 2.11 8.2
19 0.197 0.853 0.0919 1.88 n.d.
20 0.346 1.30 0.0368 1.03 7
21 0.0921 1.08 0.215 1.55 7.7
22 0.0274 1.03 0.517 2.03 8.5
23 0.0116 0.860 0.743 2.46 9.3
24 0.00648 1.18 1.46 2.99 10.2
25 0.005 1.19 1.50 3.52 10.9
26 0.00451 1.51 1.52 4.02 11.5
27 0.00312 1.07 2.63 4.79 12.1
28 0.0038 1.10 1.63 5.1 12.6
29 0.0053 1.33 1.54 5.36 13.1
30 0.00731 1.15 1.09 6.14 13.8
31 0.0113 1.20 0.941 2.24 9.2
32 0.00668 1.05 1.01 2.84 10
33 0.0977 0.963 0.224 1.5 n.d.
34 0.0157 1.32 0.744 4.4 11.5
35 0.0116 1.20 0.708 5.94 13.1
36 0.0123 0.857 0.321 6.46 n.d.
37 0.0133 1.45 0.600 4.38 11.6
38 0.00878 1.43 1.69 3.3 11.3
39 0.0196 1.14 0.605 3.62 10.7
40 0.00968 1.74 1.16 4.49 11.9
41 0.00517 1.15 1.04 6.07 n.d.
42 0.0204 0.929 0.420 6.42 13.9
43 0.0616e e 0.186 7.14 10.4


Quantitative analysis of transmembrane anion transport

Quantitative structure–transport activity (QSAR) studies represent a commonly employed approach to modelling physical and biological properties of compounds.26,33 This approach is a powerful tool for structure optimization and targeted design of new compounds. The objective of a QSAR study is the construction of a statistically relevant model. Using a combination of software sources: ALOGPS 2.1 and e-dragon 1.0,34,35 (which gave constitutional descriptors, topological descriptors, topological charge indices, geometrical descriptors, WHIM descriptors, charge descriptors and molecular properties), Chemicalize,36 ACDiLabs 2.0,37 TorchV10lite38 and ChemBioDraw 12.0 ultra software39 a total of 506 descriptors were calculated. Based on our previous observations, we identified lipophilicity as an important parameter determining the transmembrane transport efficiency of a given transporter.27 In order to obtain an experimental measure of this property, the retention times (RT) of all compounds were measured using reverse phase HPLC. In this assay, lipophilic compounds show higher retention times whereas hydrophilic compounds are eluted more quickly.40 These experiments are used as an indirect measure of the lipophilicity. On the other hand, log[thin space (1/6-em)]P, the octanol–water partition coefficient, is the more employed quantitative measure of lipophilicity. The importance of this parameter41 in medicinal chemistry and drug discovery has led to the development of several software packages to predict the log[thin space (1/6-em)]P values without the need of experimentally time consuming measures. Moreover, these predictions allow the calculation of log[thin space (1/6-em)]P values of virtual compounds. Simple correlations of the measured RT and the different calculated log[thin space (1/6-em)]P values showed an excellent agreement (see ESI, log[thin space (1/6-em)]P_RT_correlations.pdf).40 This correlation supported the validity of computationally obtained log[thin space (1/6-em)]P values for these compounds. The best correlation was found for the calculated ALOGPs values using the ALOGPs 2.1 software, therefore ALOGPs descriptor was selected as the best log[thin space (1/6-em)]P descriptor. Those values are shown in Table 1 along with RT data.

A simple plot of the transport activity, expressed as log(1/EC50), vs. ALOGPs or retention time (RT) suggested a parabolic dependence of these variables (Fig. 2a and b). The rationale behind this observation is that there is an optimum compromise in the hydrophilicity/hydrophobicity balance, which maximizes the transmembrane transport activity of a given compound.24 A too hydrophilic transporter would not partition into the phospholipid membrane whereas a too hydrophobic derivative would not be able to move away from the membrane core and thus act as a carrier. At the beginning of the modelling part of this study, a set of 38 compounds had been synthesized. However, the majority of these compounds were present in the middle of the explored ALOGPs range (values from 2–6) with only a few compounds above or below this range. Therefore, the need of including further compounds, having low and high log[thin space (1/6-em)]P values, to confirm this parabolic dependence and to avoid an excessive leverage of data corresponding to compounds displaying low activity and extreme log[thin space (1/6-em)]P values was evident. Compounds of a similar structure to the existing tambjamines were hypothesised and their ALOGPs values calculated. Those that fell in the ranges of 1–2.5 and 5–7.5 were considered suitable and suggested for synthesis. Thus, 5 additional tambjamine derivatives (numbers 19, 33, 36, 41, 43) were synthesised and measured (the additional molecules are highlighted by * in Fig. 2c). Attempts to find simple correlations between the anion transport activity and the lipophilicity of tambjamine derivatives were not satisfactory. Therefore, it was evident that a more sophisticated analysis should be made.


image file: c5sc03932k-f2.tif
Fig. 2 (a) Plot of log(1/EC50) vs. ALOGPs of the first set of 38 compounds; (b) plot of log(1/EC50) vs. RT of the first 38 compounds; (c) plot of log(1/EC50) vs. ALOGPs showing all 43 compounds, the additional molecules are highlighted by *.

Data cleaning

Prior to running any QSAR analyses the descriptor dataset was cleaned. Descriptors were removed if they were incomplete with values unavailable for some of the molecules, if the values were classed as non-numeric or if the descriptors had little or no variation across the dataset. Following the cleaning of the dataset, a total of 330 descriptors remained (see ESI, Tambjamines_dataset_cleaned.csv). The descriptor dataset still contained different calculated values of log[thin space (1/6-em)]P. Some descriptors are the square of another descriptor, e.g. ALOGPs-sq.

QSAR – stratified sampling and bootstrap

In the first stages of the investigation, the initial dataset (38 compounds) was split into a training set and a test set using conventional QSAR methods, and attempts were made to validate a number of model fits using cross-validation techniques. The cross validation methods were not successful with this dataset. Although the dataset is of a reasonable size, splitting the dataset into a training and test set resulted in a test set only containing 6 compounds. Due to the parabolic relationship between log(1/EC50) and log[thin space (1/6-em)]P and high leverage of the few molecules with high or low log[thin space (1/6-em)]P, the selection of the test set had an extremely large influence on the validation statistics obtained. It is apparent that if the training set were to miss out even a few of the high and low log[thin space (1/6-em)]P molecules then the most reasonable fit would simply be a line almost independent of log[thin space (1/6-em)]P.

To cope with the leverage of the high and low log[thin space (1/6-em)]P molecules, a stratified test set selection method was employed, ensuring that compounds were selected for the low, mid and high log[thin space (1/6-em)]P ranges. However, the size of the dataset and the relatively few molecules in the strata does not allow for much flexibility in the selection. To minimise test set selection bias and maximize the information from all the molecules in the dataset, a bootstrap method was selected as a suitable method for validation of the model fits. Using the bootstrap package, boot, in R,42,43 the data were sampled from the full dataset and the statistics calculated, using a resampling of the dataset 999 times. Comparing the confidence intervals for the bootstrap fit and the linear least squares prediction highlights the reasonable robustness of the fits.

QSAR models

The first avenue that was explored was fitting the whole dataset to one model. The full descriptor set was examined in JMP,44 and using the stepwise fit a ‘fit all models’ was run, modelling the log(1/EC50) against the set of descriptors with a maximum of three parameters for the model (four parameters generated too many models for the available computing power, four parameter models were generated with a subset of descriptors). The modelling considered ALOGPs and ALOGP-sq as lipophilicity descriptors. As described earlier, the ALOGPs descriptor was identified as the best log[thin space (1/6-em)]P descriptor through correlation with retention times (RT) (for full correlations see ESI (log[thin space (1/6-em)]P_RT_correlations.pdf)).

The simple parabolic two parameter model (ALOGPs, ALOGP-sq) generates the following eqn (1) with an R2 value of 0.629:

 
Log(1/EC50) = −0.579 + 1.203ALOGPs − 0.133ALOGPs-sq(1)

Increasing the number of parameters to three increased the R2 value to approximately 0.79 for the top models. All the top 20 models have an R2 value above 0.74. Summary information about the 10 best three-parameter models to the whole dataset is shown in Table 2, ranked by R2 values (additional models can be seen in ESI).

Table 2 Best fitted 3 and 4 parameter models, ranked by R2 values. 4 parameter models are fitted with a small subset
No. des. Descriptors R 2
3 ALOGPs ALOGPs-sq Mv 0.7901
3 ALOGPs ALOGPs-sq J3D 0.7892
3 ALOGPs ALOGPs-sq Mp 0.7836
3 ALOGPs ALOGPs-sq nH 0.7822
3 ALOGPs ALOGPs-sq AMW 0.7768
3 ALOGPs ALOGPs-sq J 0.7680
3 ALOGPs ALOGPs-sq E3u 0.7672
3 ALOGPs ALOGPs-sq ARR 0.7654
3 ALOGPs ALOGPs-sq Density (g cm−3) 0.7615
3 ALOGPs ALOGPs-sq Surface tension (dyne cm−1) 0.7571
4 ALOGPs ALOGPs-sq nCIC J3D 0.8160
4 ALOGPs ALOGPs-sq nH J 0.8152
4 ALOGPs ALOGPs-sq AMW J 0.8151
4 ALOGPs ALOGPs-sq AMW J3D 0.8141
4 ALOGPs ALOGPs-sq J3D Ui 0.8140
4 ALOGPs ALOGPs-sq Density (g cm−3) J3D 0.8138
4 ALOGPs ALOGPs-sq Density (g cm−3) J 0.8121
4 ALOGPs ALOGPs-sq Parachor (cm3) nH 0.8099
4 ALOGPs ALOGPs-sq Molar refractivity (cm3) nH 0.8085
4 ALOGPs ALOGPs-sq Polarizability (cm3) nH 0.8084


Following the ‘fit all models’ fit, confidence intervals were obtained for a selected number of models from the least-squares analysis. These models were then also run through a bootstrap method in R to obtain confidence intervals using a sampling method. Due to the distribution of the data still being heavily biased towards the middle of the ALOGPs range, we utilised a stratified selection within the bootstrap function to ensure that a selection of points from the lower and upper regions were always included.

Confidence intervals obtained from the bootstrap function were well aligned with the confidence intervals obtained from the linear fit (Table 3) (see ESI for additional details). This suggests that the fits are quite robust. The most variation comes in the coefficient for the intercept with a much narrower range in the ALOGPs and ALOGPs-sq coefficients. However, plotting actual vs. predicted for the models gives a fairly similar appearance for all of the selection of ten models (see ESI for details).

Table 3 Coefficients and confidence intervals for the best two, three and four parameter models
Coefficients Model parameters ALOGPs ALOGPs-sq ALOGPs ALOGPs-sq Mv ALOGPs ALOGPs-sq nCIC J3D
R 2 0.6292 0.7901 0.816
Intercept −0.579 3.362 −5.105
Linear fit 2.5% C.I. −1.165 1.838 −7.579
97.5% C.I. 0.008 4.887 −2.632
Bootstrap 2.5% C.I. −1.108 2.159 −7.681
97.5% C.I. −0.086 4.419 −2.694
ALOGPs 1.203 1.372 1.284
Linear fit 2.5% C.I. 0.903 1.135 1.056
97.5% C.I. 1.504 1.610 1.511
Bootstrap 2.5% C.I. 0.904 1.126 1.087
97.5% C.I. 1.470 1.579 1.493
ALOGPs-sq −0.133 −0.158 −0.146
Linear fit 2.5% C.I. −0.168 −0.186 −0.172
97.5% C.I. −0.098 −0.129 −0.120
Bootstrap 2.5% C.I. −0.166 −0.190 −0.173
97.5% C.I. −0.093 −0.123 −0.116
3rd parameter −6.616 0.411
Linear fit 2.5% C.I. −9.063 0.057
97.5% C.I. −4.168 0.764
Bootstrap 2.5% C.I. −8.432 0.064
97.5% C.I. −4.473 0.796
4th parameter 1.587
Linear fit 2.5% C.I. 0.808
97.5% C.I. 2.367
Bootstrap 2.5% C.I. 0.796
97.5% C.I. 2.330


As shown by the models described in Table 2, there were a large number of calculated descriptors that seemed to offer potentially useful additional descriptive power to the fits, but without any clear advantage of one over the others (apart from the clear importance of log[thin space (1/6-em)]P). This suggested that principle component analysis and partial least squares analysis might be useful. However, this led to insignificant improvements in the models, and made the contributions of the terms in the models less clear. Therefore, we sought an alternative classification approach along the lines of partial decisions trees by modelling subsets of the compounds based on the structural features of the molecules.

Structural classification

The compounds in this series share a bipyrrole core structure, and the rest of the structure can be categorised by three variations on backbone structure (see Fig. 3). The R4 position on the heterocycle (ring-substituent) is either occupied by an OMe group or by an OBn group, the R5 position (enamine-substituent) is either an NH group or a NH–Ph moiety (with two exceptions: compound 19 is NH–CH2–Ph and compound 38 is NH–py), the R6 substituent (R-group) is quite varied but can be grouped into the type of substituent e.g. alkyl, halogen, etc. The presence or absence of a structural feature is a key aspect which could have an effect on the activity of a molecule. Due to this we looked into separating the set of molecules into groups by the structural substituents.
image file: c5sc03932k-f3.tif
Fig. 3 Backbone structure of tambjamines (left). Overlay of compounds side on and face on (green – compound 7, red – compound 25, grey – compound 37) highlighting the similarities and differences of the structural subgroups (right).

Splitting by ring-substituent R4 gives two groups: thirty-three compounds with a methoxy group and ten compounds with a –OBn substituent (Fig. 4a). Splitting considering R5 group gives two main groups and two points that do not fit into either the NH or NH–Ph classification. The NH group has nineteen compounds and the NH–Ph group has twenty-two compounds (Fig. 4b). Splitting by the R6 group is fairly difficult as there are a variety of different substituents. The most populated group is that in which R6 is an alkyl group, with twenty-eight compounds. The remaining fifteen compounds fit into six other groups (Fig. 4c).


image file: c5sc03932k-f4.tif
Fig. 4 Plot of log(1/EC50) vs. ALOGPs splitting the dataset by different substituents: (a) ring-substituent (R4), (b) enamine-substituent (R5), (c) R-type (R6), see Fig. 3.

The subset with the most interesting grouping involves the split by enamine-substituent R5 (Fig. 4b). From plotting log(1/EC50) against ALOGPs (assuming a parabolic relationship) we have two sets of data where the peak log(1/EC50) values appears to change between the two sets. However the optimum log[thin space (1/6-em)]P value appears to be similar for the two sets. The R-type plot shows a nice parabolic relationship for the R6 alkyl R-type, however the other groups are not populated well enough to show a proper correlation. The reason for this is that in the NH group set the main substituent that is possible is an alkyl chain. On the other hand, with the phenyl ring in NH–Ph there is the opportunity to substitute a wider variety of R-types. Since there is only a substitution at the para position it limits the number of compounds that will have the same R-type substituent. Due to this we choose to take only those compounds with an alkyl substituent and carry out modelling of the subset using the lme4 package,45,46 in R. This package allows us to use an entire dataset to fit the curve of the parabola, whilst allowing the subset of data to adjust the positioning of the curve by changing the intercept. A linear mixed effect model (lmer) was run for the subset of the compounds containing an alkyl R-type, modelling the dataset to the form log(1/EC50) = a + b × ALOGPs + c × ALOGP2, and further splitting by the substituent R4. See Fig. 5.


image file: c5sc03932k-f5.tif
Fig. 5 lmer fit and model for the alkyl R type for both OMe and OBn ring substituents (coefficients for ALOGPs and ALOGPs-sq are fitted using all datapoints). Points coloured by enamine-substituent: black – NH, green – NH–Ph. Shape by ring-substituent: circle – OBn, triangle – OMe.

Taking only the OMe ring substituted compounds (20 of the 28 alkyl compounds) results in the following lmer model and plot (Fig. 6).


image file: c5sc03932k-f6.tif
Fig. 6 lmer fit and model for the alkyl R type, OMe ring substituent (coefficients for ALOGPs and ALOGPs-sq are fitted using all datapoints). Points coloured by enamine-substituent: black – NH, green – NH–Ph.

These models show that extending a hydrocarbon tail certainly has the classic parabolic behaviour on log[thin space (1/6-em)]P with the optimum value of log[thin space (1/6-em)]P (and the curvature) being a property of the membrane (so similar for many of the subsets). The effect of the other substituent (OMe) and (OBn) in changing the maximum value of log(1/EC50) is demonstrated but we are less clear what is driving this effect and this will be a subject for further investigation.

Fig. 7 shows that by defining several sub-groups of substituents in terms of substituent location and chemical type we are able to demonstrate the parabolic dependence on log[thin space (1/6-em)]P and begin to highlight the aspects that are a property of the membrane and those that depend on more specific interactions between the membrane and the tambjamine molecules. The parabolic dependence observed is a property of the membrane. However, each substituent series is shifted in optimal log[thin space (1/6-em)]P for transport. This evidence leads us to suggest that whilst for relatively simple substituents in certain locations on the tambjamine core, hydrophobic interactions dominate, for others more specific interactions are present that change the position of the membrane hydrophobicity parabolic envelope. The functions illustrated in Fig. 7 are presented in Table 4.


image file: c5sc03932k-f7.tif
Fig. 7 Quadratic fits for all types of compound grouping, excludes groups with less than 3 points, showing behaviour consistent with a parabolic dependence on log[thin space (1/6-em)]P but with differing optimum values of log[thin space (1/6-em)]P suggesting that other aspects of the mechanism may be more significant in these cases. Groups are classified by the following substituents; R4.R5.R6(R-type).
Table 4 Model equations and R2 values for quadratic fits of compound grouping shown in Fig. 7 modelling for log(1/EC50)
Sub group Equation fit R 2
OBn.NH.alkyl Y = −4.783 + 2.737 × ALOGPs − 0.2656 × ALOGPs2 0.84
OBn.NH–Ph.alkyl Y = −0.2663 + 0.7575 × ALOGPs − 0.06513 × ALOGPs2 0.999
OMe.NH.alkyl Y = −0.8097 + 1.509 × ALOGPs − 0.1707 × ALOGPs2 0.97
OMe.NH–Ph.alkyl Y = 0.1699 + 1.088 × ALOGPs − 0.1456 × ALOGPs2 0.999
OMe.NH–Ph.halogen Y = −6.332 + 4.936 × ALOGPs − 0.7501 × ALOGPs2 0.48
OMe.NH–Ph.O–R′ Y = −13.52 + 9.364 × ALOGPs − 1.42 × ALOGPs2 0.98


Conclusions

This study demonstrates the generality of lipophilicity as a crucial parameter governing the transmembrane transport activity of synthetic anionophores. Series of structurally similar compounds containing a common hydrogen bonding motif and a variety of substitution patterns can be grouped in subsets according to structural parameters. In general there is a parabolic dependence between log(1/EC50) and log[thin space (1/6-em)]P which is a property of the membrane. By defining subgroups of substituents and splitting the data, optimum log[thin space (1/6-em)]P values for each sub-group were obtained. This suggests that for different sub-groups of compounds specific interactions are taking place that change the optimum log[thin space (1/6-em)]P value. We have thus gained significant insight into how substitution affects the anion transport properties of this important class receptor.

Acknowledgements

Andrea Sancho is gratefully acknowledged for contributions to synthesis of the compounds. Julie Herniman is thanked for the retention time studies. KT acknowledges contributions from Summer Exchange Research Program (SERP) of Graduate School of Engineering, Tokyo Institute of Technology. RQ acknowledges funding from Consejería de Educación de la Junta de Castilla y León (Project BU340U13) and Fundació la Marató de TV3 (20132730). PAG thanks the EPSRC for funding (EP/J009687/1 and EP/K039466/1) and the Royal Society and the Wolfson Foundation for a Royal Society Wolfson Research Merit Award. We thank COST CM1005 Supramolecular Chemistry in Water for a STSM (EH). JGF thanks the EPSRC (GR/R67729 & EP/K003569) for funding.

Notes and references

  1. M. M. Faul and B. E. Huff, Chem. Rev., 2000, 100, 2407 CrossRef CAS PubMed.
  2. I. Alfonso and R. Quesada, Chem. Sci., 2013, 4, 3009 RSC.
  3. N. Busschaert and P. A. Gale, Angew. Chem., Int. Ed., 2013, 52, 1374 CrossRef CAS PubMed; N. Busschaert, C. Caltagirone, W. van Rossom and P. A. Gale, Chem. Rev., 2015, 115, 8038 CrossRef PubMed.
  4. N. Sakai and S. Matile, Langmuir, 2013, 29, 9031 CrossRef CAS PubMed.
  5. S. Matile, A. Vargas Jentzsch, J. Montenegro and A. Fin, Chem. Soc. Rev., 2011, 40, 2453 RSC.
  6. J. T. Davis, O. Okunola and R. Quesada, Chem. Soc. Rev., 2010, 39, 3843 RSC.
  7. T. M. Fyles, Chem. Soc. Rev., 2007, 36, 335 RSC.
  8. A. P. Davis, D. N. Sheppard and B. D. Smith, Chem. Soc. Rev., 2007, 36, 348 RSC.
  9. F. M. Ashcroft, Nature, 2006, 440, 440 CrossRef CAS PubMed.
  10. F. M. Ashcroft, Ion Channels and Disease, Academic Press, San Diego and London, 2000 Search PubMed.
  11. J. T. Davis, Top. Heterocycl. Chem., 2010, 24, 145 CAS.
  12. A. Fürstner, Angew. Chem., Int. Ed., 2003, 42, 3582 CrossRef PubMed.
  13. N. R. Williamson, P. C. Fineran, F. J. Leeper and G. P. C. Salmond, Nat. Rev. Microbiol., 2006, 4, 887 CrossRef CAS PubMed.
  14. N. R. Williamson, P. C. Fineran, T. Gristwood, S. R. Chawrai, F. J. Leeper and G. P. C. Salmond, Future Microbiol., 2007, 2, 605 CrossRef CAS PubMed.
  15. B. Díaz de Greñu, P. Iglesias Hernández, M. Espona, D. Quiñonero, M. E. Light, T. Torroba, R. Pérez-Tomás and R. Quesada, Chem.–Eur. J., 2011, 17, 14074 CrossRef PubMed.
  16. P. A. Gale, R. Peréz-Tomás and R. Quesada, Acc. Chem. Res., 2013, 46, 2801 CrossRef CAS PubMed.
  17. J. L. Sessler, L. R. Eller, W.-S. Cho, S. Nicolaou, A. Aguilar, J. T. Lee, V. M. Lynch and D. J. Magda, Angew. Chem., Int. Ed., 2005, 44, 5989 CrossRef CAS PubMed.
  18. S. Rastogi, E. Marchal, I. Uddin, B. Groves, J. Colpitts, S. A. McFarland, J. T. Davis and A. Thompson, Org. Biomol. Chem., 2013, 11, 3834 CAS.
  19. P. Iglesias Hernández, D. Moreno, A. Araujo Javier, T. Torroba, R. Pérez-Tomás and R. Quesada, Chem. Commun., 2012, 48, 1556 RSC.
  20. C. J. E. Haynes and P. A. Gale, Chem. Commun., 2011, 47, 8203 RSC.
  21. S. Hussain, P. R. Brotherhood, L. W. Judd and A. P. Davis, J. Am. Chem. Soc., 2011, 133, 1614 CrossRef CAS PubMed.
  22. L. Adriaenssens, C. Estarellas, A. Vargas Jentzsch, M. M. Belmonte, S. Matile and P. Ballester, J. Am. Chem. Soc., 2013, 135, 8324 CrossRef CAS PubMed.
  23. J. L. Atkins, M. B. Patel, M. M. Daschbach, J. W. Meisel and G. W. Gokel, J. Am. Chem. Soc., 2012, 134, 13546 CrossRef CAS PubMed.
  24. V. Saggiomo, S. Otto, I. Marques, V. Félix, T. Torroba and R. Quesada, Chem. Commun., 2012, 48, 5274 RSC.
  25. H. Valkenier, C. J. E. Haynes, J. Herniman, P. A. Gale and A. P. Davis, Chem. Sci., 2014, 5, 1128 RSC.
  26. A. Cherkasov, E. N. Muratov, D. Fourches, A. Varnek, I. I. Baskin, M. Cronin, J. Dearden, P. Gramatica, Y. C. Martin, R. Todeschini, V. Consonni, V. E. Kuz'min, R. Cramer, R. Benigni, C. Yang, J. Rathman, L. Terfloth, J. Gasteiger, A. Richard and A. Tropsha, J. Med. Chem., 2014, 57, 4977 CrossRef CAS PubMed.
  27. N. Busschaert, S. J. Bradberry, M. Wenzel, C. J. E. Haynes, J. R. Hiscock, I. L. Kirby, L. E. Karagiannidis, S. J. Moore, N. J. Wells, J. Herniman, G. J. Langley, P. N. Horton, M. E. Light, I. Marques, P. J. Costa, V. Felix, J. G. Frey and P. A. Gale, Chem. Sci., 2013, 4, 3036 RSC.
  28. D. M. Pinkerton, M. G. Banwell and A. C. Willis, Org. Lett., 2007, 9, 5127 CrossRef CAS PubMed.
  29. E. Hernando, V. Soto-Cerrato, S. Cortés-Arroyo, R. Pérez-Tomás and R. Quesada, Org. Biomol. Chem., 2014, 12, 1771 CAS.
  30. A. V. Koulov, T. N. Lambert, R. Shukla, M. Jain, J. M. Boon, B. D. Smith, H. Li, D. N. Sheppard, J.-B. Joos, J. P. Clare and A. P. Davis, Angew. Chem., Int. Ed., 2003, 42, 4931 CrossRef CAS PubMed.
  31. A. V. Hill, Biochem. J., 1913, 7, 471 CrossRef CAS PubMed.
  32. S. Bhosale and S. Matile, Chirality, 2006, 18, 849 CrossRef CAS PubMed.
  33. C. Hansch, A. S. Ruth, S. M. Anderson and D. L. Bentley, J. Med. Chem., 1968, 11, 1 CrossRef CAS PubMed.
  34. VCCLAB, Virtual Computational Chemistry Laboratory, ALOGPS 2.1 and e-Dragon 1.0, http://www.vcclab.org, accessed August 2013 Search PubMed.
  35. I. Tetko, J. Gasteiger, R. Todeschini, A. Mauri, D. Livingstone, P. Ertl, V. Palyulin, E. Radchenko, N. Zefirov, A. Makarenko, V. Tanchuk and V. Prokopenko, J. Comput.-Aided Mol. Des., 2005, 19, 453 CrossRef CAS PubMed.
  36. Chemicalize, http://www.chemicalize.org/, accessed August 2013.
  37. ACD/I-Lab 2.0, https://ilab.acdlabs.com/iLab2/, accessed August 2013 Search PubMed.
  38. Fieldview, version 2.0.2, Cresset BMD Ltd., Hertfordshire, UK, 2011 Search PubMed.
  39. Chemdraw Ultra, 12.0, Cambridge SoftCorporation, Cambridge, USA, 1986-2010 Search PubMed.
  40. T. Braumann, J. Chromatogr. A, 1986, 373, 191 CrossRef CAS PubMed.
  41. C. A. Lipinski, F. Lombardo, B. W. Dominy and P. J. Feeney, Adv. Drug Delivery Rev., 1997, 23, 3 CrossRef CAS.
  42. R package version 1.3-17, Angelo Canty and Brian Ripley (2015), boot: Bootstrap R (S-Plus) Functions.
  43. A. C. Davison and D. V. Hinkley, Bootstrap Methods and Their Applications, Cambridge University Press, Cambridge, 1997 Search PubMed.
  44. JMP® Pro, version 11.2.0., SAS Institute Inc., Cary, NC, 1989-2013 Search PubMed.
  45. D. Bates, M. Maechler, B. Bolker and S. Walker, lme4: Linear mixed-effects models using Eigen and S4, R package version 1.1-8, 2015, http://CRAN.R-project.org/package=lme4, accessed June 2015 Search PubMed.
  46. D. Bates, M. Maechler, B. M. Bolker and S. Walker, J. Stat. Software, 2015, 67, 1–48 Search PubMed.

Footnotes

Electronic supplementary information (ESI) available: Synthesis of new compounds, anion transport studies and details of the QSAR analysis. See DOI: 10.1039/c5sc03932k
The underlying research data for this paper are available in accordance with EPSRC open data policy from http://dx.doi.org/10.5258/SOTON/384138
§ Present address: Department of Chemistry, University of Cambridge, Lensfield Rd, Cambridge, CB2 1EW.
Present address: Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, UK.

This journal is © The Royal Society of Chemistry 2016